DK1558226T3 - Fremgangsmåde til cardiobeskyttelse og neurobeskyttelse ved intravenøs indgivelse af halogenerede, flygtige anæstetika - Google Patents
Fremgangsmåde til cardiobeskyttelse og neurobeskyttelse ved intravenøs indgivelse af halogenerede, flygtige anæstetikaInfo
- Publication number
- DK1558226T3 DK1558226T3 DK03774657.5T DK03774657T DK1558226T3 DK 1558226 T3 DK1558226 T3 DK 1558226T3 DK 03774657 T DK03774657 T DK 03774657T DK 1558226 T3 DK1558226 T3 DK 1558226T3
- Authority
- DK
- Denmark
- Prior art keywords
- cardioprotection
- neuroprotection
- intravenous administration
- ischemic event
- halogenated volatile
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229940035674 anesthetics Drugs 0.000 title 1
- 230000005961 cardioprotection Effects 0.000 title 1
- 239000003193 general anesthetic agent Substances 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 230000004112 neuroprotection Effects 0.000 title 1
- 230000000302 ischemic effect Effects 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000003983 inhalation anesthetic agent Substances 0.000 abstract 1
- 230000002107 myocardial effect Effects 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41793402P | 2002-10-11 | 2002-10-11 | |
| PCT/US2003/031826 WO2004032858A2 (en) | 2002-10-11 | 2003-10-09 | Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1558226T3 true DK1558226T3 (da) | 2012-05-07 |
Family
ID=32094122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03774657.5T DK1558226T3 (da) | 2002-10-11 | 2003-10-09 | Fremgangsmåde til cardiobeskyttelse og neurobeskyttelse ved intravenøs indgivelse af halogenerede, flygtige anæstetika |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7999011B2 (enExample) |
| EP (1) | EP1558226B1 (enExample) |
| JP (1) | JP5210486B2 (enExample) |
| KR (2) | KR20120030598A (enExample) |
| CN (2) | CN1703209A (enExample) |
| AT (1) | ATE546136T1 (enExample) |
| AU (1) | AU2003282464B2 (enExample) |
| BR (1) | BR0314617A (enExample) |
| CA (1) | CA2500310C (enExample) |
| DK (1) | DK1558226T3 (enExample) |
| ES (1) | ES2382911T3 (enExample) |
| HK (1) | HK1079703A1 (enExample) |
| IL (1) | IL167472A (enExample) |
| MX (1) | MXPA05003741A (enExample) |
| NZ (1) | NZ539298A (enExample) |
| PL (1) | PL219493B1 (enExample) |
| RU (1) | RU2350323C2 (enExample) |
| WO (1) | WO2004032858A2 (enExample) |
| ZA (1) | ZA200502741B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL160570A0 (en) | 2001-09-26 | 2004-07-25 | Baxter Int | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
| CA2921578C (en) | 2002-12-24 | 2017-02-14 | Rinat Neuroscience Corp. | Anti-ngf antibodies and methods using same |
| WO2008036858A2 (en) * | 2006-09-20 | 2008-03-27 | The Board Of Regents Of The University Of Texas System | Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
| GB0619499D0 (en) | 2006-10-03 | 2006-11-08 | Lucent Technologies Inc | Encrypted data in a wireless telecommunications system |
| WO2009059989A1 (de) * | 2007-11-06 | 2009-05-14 | B. Braun Melsungen Ag | Einen hydrophoben wirkstoff enthaltende wässrige emulsionen |
| WO2009094459A1 (en) * | 2008-01-22 | 2009-07-30 | The Board Of Regents Of The University Of Texas System | Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief |
| AU2015200210B2 (en) * | 2008-01-22 | 2016-08-11 | The Board Of Regents Of The University Of Texas System | Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief |
| CN102006903A (zh) * | 2008-01-22 | 2011-04-06 | 维波真尼克斯公司 | 挥发性麻醉组合物和应用方法 |
| CA3031836A1 (en) | 2009-05-05 | 2010-11-11 | Board Of Regents, The University Of Texas System | Formulations of volatile anesthetics for reducing inflammation |
| US20120219596A1 (en) | 2009-07-30 | 2012-08-30 | Wendelin Stark | Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event |
| RU2408396C1 (ru) * | 2009-07-30 | 2011-01-10 | Государственное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия Федерального агентства по здравоохранению и федеральному развитию" | Комбинированная двухсегментарная регионарная анестезия при выполнении каротидной эндартерэктомии у больных критической ишемией нижних конечностей и выраженным болевым синдромом |
| FR2956323B1 (fr) * | 2010-02-15 | 2013-12-20 | Air Liquide | Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques |
| CN107260670A (zh) * | 2011-06-24 | 2017-10-20 | 维普詹尼克斯公司 | 用于治疗皮肤病症或疾病的新型制剂和方法 |
| JP6669645B2 (ja) * | 2013-03-15 | 2020-03-18 | ベイポジェニックス インコーポレイテッド | 新規な鎮痛組成物 |
| ITMO20130075A1 (it) * | 2013-03-22 | 2014-09-23 | Enrico Giuliani | Dispositivo di somministrazione |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1018773A (en) * | 1962-09-13 | 1966-02-02 | Bellon Labor Sa Roger | ª‡-phenyl-ª‰-2-furyl-propionitrile derivatives |
| US4073943A (en) | 1974-09-11 | 1978-02-14 | Apoteksvarucentralen Vitrum Ab | Method of enhancing the administration of pharmalogically active agents |
| US5628930A (en) | 1992-10-27 | 1997-05-13 | Alliance Pharmaceutical Corp. | Stabilization of fluorocarbon emulsions |
| US5635538A (en) | 1993-03-16 | 1997-06-03 | Alliance Pharmaceutical Corp. | Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| JP2961034B2 (ja) * | 1993-09-16 | 1999-10-12 | アルプス電気株式会社 | 磁気ヘッド |
| WO1995008544A1 (en) * | 1993-09-24 | 1995-03-30 | The University Of British Columbia | Aminocyclohexylesters and uses thereof |
| FR2726267B1 (fr) * | 1994-10-26 | 1998-01-02 | Smithkline Beecham Lab | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |
| GB2350297A (en) * | 1999-05-27 | 2000-11-29 | Abbott Lab | Injectable halogenated anesthetic formulation in emulsion form |
| CA2416535C (en) | 2000-07-26 | 2010-11-16 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
-
2003
- 2003-10-09 CN CNA2003801012256A patent/CN1703209A/zh active Pending
- 2003-10-09 MX MXPA05003741A patent/MXPA05003741A/es active IP Right Grant
- 2003-10-09 CA CA2500310A patent/CA2500310C/en not_active Expired - Fee Related
- 2003-10-09 HK HK05112083.8A patent/HK1079703A1/zh unknown
- 2003-10-09 AU AU2003282464A patent/AU2003282464B2/en not_active Ceased
- 2003-10-09 RU RU2005114008/14A patent/RU2350323C2/ru not_active IP Right Cessation
- 2003-10-09 JP JP2004543499A patent/JP5210486B2/ja not_active Expired - Lifetime
- 2003-10-09 US US10/682,303 patent/US7999011B2/en active Active
- 2003-10-09 NZ NZ539298A patent/NZ539298A/en not_active IP Right Cessation
- 2003-10-09 CN CN2011101820964A patent/CN102283821A/zh active Pending
- 2003-10-09 WO PCT/US2003/031826 patent/WO2004032858A2/en not_active Ceased
- 2003-10-09 BR BR0314617-0A patent/BR0314617A/pt not_active Application Discontinuation
- 2003-10-09 DK DK03774657.5T patent/DK1558226T3/da active
- 2003-10-09 PL PL376217A patent/PL219493B1/pl unknown
- 2003-10-09 KR KR1020127005009A patent/KR20120030598A/ko not_active Ceased
- 2003-10-09 EP EP03774657A patent/EP1558226B1/en not_active Expired - Lifetime
- 2003-10-09 AT AT03774657T patent/ATE546136T1/de active
- 2003-10-09 KR KR1020057006049A patent/KR101403264B1/ko not_active Expired - Fee Related
- 2003-10-09 ES ES03774657T patent/ES2382911T3/es not_active Expired - Lifetime
-
2005
- 2005-03-16 IL IL167472A patent/IL167472A/en active IP Right Grant
- 2005-04-05 ZA ZA200502741A patent/ZA200502741B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101403264B1 (ko) | 2014-06-02 |
| WO2004032858A2 (en) | 2004-04-22 |
| WO2004032858A3 (en) | 2004-09-23 |
| HK1079703A1 (zh) | 2006-04-13 |
| CN102283821A (zh) | 2011-12-21 |
| MXPA05003741A (es) | 2005-06-17 |
| ZA200502741B (en) | 2006-02-22 |
| BR0314617A (pt) | 2005-08-02 |
| US20040127578A1 (en) | 2004-07-01 |
| EP1558226A2 (en) | 2005-08-03 |
| AU2003282464A1 (en) | 2004-05-04 |
| US7999011B2 (en) | 2011-08-16 |
| NZ539298A (en) | 2008-11-28 |
| PL376217A1 (en) | 2005-12-27 |
| IL167472A (en) | 2013-10-31 |
| AU2003282464B2 (en) | 2010-02-25 |
| KR20050056230A (ko) | 2005-06-14 |
| KR20120030598A (ko) | 2012-03-28 |
| JP5210486B2 (ja) | 2013-06-12 |
| PL219493B1 (pl) | 2015-05-29 |
| ATE546136T1 (de) | 2012-03-15 |
| ES2382911T3 (es) | 2012-06-14 |
| CN1703209A (zh) | 2005-11-30 |
| JP2006504740A (ja) | 2006-02-09 |
| EP1558226B1 (en) | 2012-02-22 |
| RU2005114008A (ru) | 2005-10-27 |
| CA2500310A1 (en) | 2004-04-22 |
| EP1558226A4 (en) | 2008-04-02 |
| RU2350323C2 (ru) | 2009-03-27 |
| CA2500310C (en) | 2013-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1558226T3 (da) | Fremgangsmåde til cardiobeskyttelse og neurobeskyttelse ved intravenøs indgivelse af halogenerede, flygtige anæstetika | |
| Compere et al. | Major complications after 400 continuous popliteal sciatic nerve blocks for post‐operative analgesia | |
| DE69921650D1 (de) | Patientenspezifische dosimetrie | |
| JP2006501240A5 (enExample) | ||
| TR200001891T2 (tr) | ASPB28- İnsan ensülini ve kullanımı. | |
| KR100535554B1 (ko) | 소아과 수술에서의 레보부피바카인의 용도 | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| DE60018097D1 (de) | Sicherheitsmechanismus zum vorbeugen von unbeabsichtigter patienteninjektion sowie methode | |
| Gupta et al. | “Sodium bicarbonate”: an adjunct to painless palatal anesthesia | |
| Jayakaran et al. | Local anesthetics in pediatric dental practice | |
| Alioto et al. | Hematoma block for ankle fractures: a safe and efficacious technique for manipulations | |
| Kulkarni et al. | Painless anaesthesia in pediatric dentistry: an updated review | |
| DK1638492T3 (da) | Præoperativ behandling af postoperativ smerte | |
| DE60120917D1 (de) | Kombinationspräparat zur krebstherapie | |
| WO2001080895A3 (en) | Methods and compositions for the treatment of cardiac indications | |
| EP1180380A3 (en) | Catheter apparatus for medical treatment | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| ATE446309T1 (de) | Den kapillarwiderstand verbessernde peptidsubstanz, darauf basierende pharmazeutische zusammensetzung und verfahren zu deren anwendung | |
| El Tallawy et al. | Comparative study between surgical wound catheter, femoral nerve block, and adductor Canal block for postoperative analgesia after knee arthroplasty: A double blind randomized clinical trial | |
| Padmanabhan et al. | Dental Anesthesia: Can Needle-Free Injections Help | |
| EA200600757A1 (ru) | Тетрапептид, регулирующий уровень глюкозы в крови при сахарном диабете | |
| Yaacob et al. | The efficacy of xylocaine topical anaesthetic in reducing injection pain | |
| Srivastava et al. | Clinical Evaluation Of Effects Of Acupuncture Anesthesia In Extraction Of Tooth. | |
| RU2016124135A (ru) | Способы применения (+)-1,4-дигидро-7-[(3s,4s)-3-метокси-4-(метиламино)-1-пирролидинил]-4-оксо-1-(2-тиазолил)-1,8-нафтиридин-3-карбоновой кислоты для лечения рака | |
| Crombez et al. | Remifentanil: an attractive sedative for retrogasserian glycerol injection |